Medibio Ltd logo

Medibio Ltd (MEB)

Delisted
ASX ASX
6.1M Market Cap
- P/E Ratio
- Div Yield
1.44M Volume
- Eps
Want to track MEB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.

Medibio Ltd (MEB) FAQ

What does "Delisted" mean?

Medibio Ltd has been removed from the exchange and is no longer publicly traded.

What was the last recorded dividend?

No dividend payments were recorded prior to delisting.

How long did the company pay dividends?

The company did not have a dividend payment history.

Were there any stock splits?

The last recorded stock split occurred on Oct 23, 2023 with a ratio of 1:20.

What was the last known trading price?

The stock last traded at A$0.00 on Sep 11, 2023 before being delisted.

Medibio Ltd Profile

Insurance Industry
Financials Sector
Dr. Thomas Richard Young M.D. CEO
ASX Exchange
Q5922F102 CUSIP
Australia Country
- Employees
- Last Dividend
23 Oct 2023 Last Split
- IPO Date

Overview

Medibio Limited is a pioneering health technology company operating out of Mount Lawley, Australia, with its efforts focused on the international stage, particularly in Australia and the United States. The company's mission revolves around the advancement of diagnostic and screening techniques for mental health conditions. Initially established under the name BioProspect Limited in 1987, it underwent a significant transformation, rebranding to Medibio Limited in November 2014. This rebranding marked the company's strategic pivot towards mental health technologies, reinforcing its commitment to addressing the challenges within this critical domain of healthcare.

Products and Services

Medibio Limited has developed a suite of innovative products and services designed to support mental well-being in various contexts, each tailored to meet the diverse needs of its users:

  • Corporate Health Product: This offering is targeted towards businesses seeking to enhance the mental wellness of their workforce. Medibio's corporate health product leverages cutting-edge technology to provide companies with tools for effective mental health screening and management among employees. The objective is to foster a healthier work environment, reduce absenteeism, and contribute positively to overall productivity and employee satisfaction.
  • Healthcare Provider Market Products: In addition to its corporate solutions, Medibio is also developing products specifically designed for the healthcare provider market. These tools aim to revolutionize the diagnosis and treatment of mental health conditions by offering more precise and reliable screening processes. By facilitating early detection and intervention, Medibio seeks to significantly improve patient outcomes, offering healthcare professionals breakthrough solutions in the management of mental health disorders.

Contact Information

Address: 647 Beaufort Street
Phone: 61 8 6189 1155